Why Opioids Are ‘An Everything Problem’

The coal region of Pennsylvania has struggled with opioids for years.

The coal region of Pennsylvania has struggled with opioids for years. Shutterstock

 

Connecting state and local government leaders

New research supports the idea that economic distress sparked the opioid epidemic. But others say the true causes are far more complicated.

In 2015, Jennifer Silva, a professor of sociology and anthropology at Bucknell University, began interviewing people in the coal region of northeastern Pennsylvania. She was working on a project, which would become the book We’re Still Here, about how poor and working-class Americans were affected by the collapse of the coal industry—the major job provider in the region.

She was curious how the regional decline might have shaped her subjects’ politics. But she quickly noticed a startling trend alongside the growing unemployment: Her subjects and their families were struggling with opioid abuse. At community meetings, doctors and coroners would debate solutions to the problem. Should they be arresting people? Should they be creating support groups? She describes one desperate parent who asked whether Donald Trump’s proposed border wall would keep black tar heroin from getting to Pennsylvania.

Silva’s interviewees might have been representative of an awful connection between job loss and opioid abuse, a connection that continues to be bolstered by research. A study published on Monday in the journal JAMA found that counties with automotive assembly plants that closed had, five years after the closure, 85 percent higher rates of opioid-overdose mortality, relative to counties where automotive assembly plants remained open.

While the study authors can’t say that it was the laid-off autoworkers, specifically, who died of overdoses, the findings gave the researchers the sense that declining economic opportunities are a big part of what drove the opioid epidemic. After all, there are a number of potential connections between joblessness and addiction, says Atheendar S. Venkataramani, an assistant professor of health policy at the University of Pennsylvania and the lead author of the study. Losing a job might mean losing access to health insurance. It could lead to isolation and loneliness, or a sense that there’s little left to live for. “If you feel like the American dream is no longer accessible,” Venkataramani says, “then one may also feel that, Well, it’s not really worth investing in myself ... because investing in yourself is one way to access the fruits of the American dream.

Venkataramani’s study can be read as yet another sign that Americans are dying “deaths of despair”—that the reason the life expectancies of poor Americans are stagnating or declining is that their dwindling economic opportunities spur them toward drugs, alcohol, and suicide. Many other studies have also found connections between different types of job loss and different types of drug abuse. One 2017 paper, which I wrote about at the time, found that with each percentage-point increase in the unemployment rate, the death rate from opioids rises by 3.6 percent. Another found that economic downturns that lower housing prices, such as the Great Recession, are associated with more opioid-related deaths. A meta-analysis published in the International Journal of Drug Policy examined 28 studies published from 1990 to 2015 in 12 different countries and found that both economic recessions and individual unemployment increases illegal drug use of various kinds. And late last year, another paper found that a rise in manufacturing-related job loss corresponded with an increase in opioid-related deaths.

The authors of these studies tend to speculate that as people lose their jobs, they grow depressed, and they turn to opioids to cope. Opioids can, for some people, provide a soothing, antidepressive effect in addition to pain relief.

A social problem that has, since 1999, killed more than 700,000 Americans—about the population of Boston—has more than one cause. Rich people die from opioids, and so do college kids. In fact, these unemployment studies are tempting precisely because they provide an easy explanation for why so many people became opioid addicts all at once. Job loss is terrible—of course it could make you do something terrible. It’s harder to explain addiction that strikes you down in your prime.

In fact, some researchers say widespread job loss is far from the only—or even the main—force that inflamed the opioid epidemic. That argument, they say, might let Big Pharma off the hook too easily.

Keith Humphreys, a professor of mental health policy at Stanford, told me the car-plant-closure study had “a plausible hypothesis,” but was “flawed.” Humphreys told me the paper should have measured the supply of opioids in the counties where the automotive plants were. It should have had a “negative control,” he said—a measure of the change in something generally thought unrelated to job loss, such as the rate of Alzheimer’s diagnoses, to be sure it was picking up distress-related opioid use. Humphreys also said Venkataramani and his co-authors should have examined alcohol and suicides—two other factors that often go with opioids when it comes to the health consequences of economic despair. I don’t think this [study] would convince anybody who wasn’t convinced before they got to the first word of the article,” Humphreys said.

When I ran these criticisms by Venkataramani, he defended his findings. He said it wasn’t possible to measure the supply of opioids in the counties he studied with the available data, and that it would be difficult to find a suitable negative control for a study such as this. And there weren’t enough alcohol-related deaths and suicides to include them in the study.

Humphreys pointed out that even if the decline of manufacturing jobs did cause the opioid epidemic, it would be cold comfort to policy makers. They can’t snap their fingers and reopen scores of factories across the country. “Who doesn’t want to revive those areas?” he said. “If we knew how to bring manufacturing back, we would do it.” To stop the opioid epidemic, he argued, we should focus on changes we can actually make.

More compelling, to Humphreys, is a recent National Bureau of Economic Research paper that did examine a potential policy solution. For the paper, researchers studied the handful of states that used so-called triplicate programs for their prescriptions of opioids. Triplicates were a rudimentary type of prescription-drug-monitoring program, in which doctors were required to use a special type of pad to prescribe controlled substances, and provide a copy of the prescription to a state monitoring agency. Physicians found these forms a hassle to use, and they were therefore reluctant to prescribe the drugs that required the use of triplicates.

Purdue, the maker of OxyContin, in turn marketed its opioid painkiller less aggressively in states that used triplicates, the paper found. And as a result, fewer people died of opioid overdoses in those states. The paper found that non-triplicate states would have had an average of 44 percent fewer opioid-overdose deaths from 1996 to 2017 if they had been triplicate states. Perhaps most damning, the relationship between being a triplicate state and experiencing fewer opioid-overdose deaths held even when the authors controlled for the state’s economic conditions. In other words, despairing or not, patients who were prescribed opioids took them.

The triplicate paper, in essence, makes it look like the opioid epidemic was mostly the fault of Big Pharma’s marketing, not the result of an economic shock. But David Powell, a senior economist at Rand and an author of the triplicate paper, thinks both could be true. To get the worst drug overdose epidemic in U.S. history, he says, “you need a huge rise in opioid access, in a way that misuse is easy, but you also need demand to misuse the product.”

The next step will be for researchers to see how the marketing of opioids interacted with economic conditions to increase the likelihood that a given place would succumb to addiction. In the meantime, researchers working on the ground say opioid addiction looks like the result of a perfect storm of poverty, trauma, availability, and pain.

When Silva, the Bucknell sociologist, asked her subjects about their painkiller addictions, they would often link their problems back to the decline of coal. When the coal jobs went away, they said, families fell apart. Some people started drinking heavily and abusing their children—who then went on to be traumatized themselves and sought the relief of OxyContin. Some grew bored and aimless without a job, and they started abusing drugs to fill the time or to ease their sense of purposelessness. Some had to switch to other manual jobs, and days of heavy lifting eventually took their painful toll. OxyContin was just a short doctor’s visit away—in one case, a doctor would simply refill opioid prescriptions by phone. “The men and women in this book suffer from physical pain—muscles torn and backs worn out by heavy lifting and repetitive tasks,” Silva writes. But they also “turn to food and Percocet, heroin and cigarettes, to manage the feelings of anxiety, disappointment, and trauma from their pasts.”

Her interviewees had easy access to opioids, yes, but they also felt betrayed by the world. When Silva presented her work recently, an economist told her, “This is, like, an everything problem.”

“I thought that was a really smart way of putting it,” she told me. Indeed, in one of their studies, the Princeton economists Anne Case and Angus Deaton, who coined the “deaths of despair” hypothesis, noted that opioid overdoses, suicides, and alcohol abuse are the results of “cumulative distress,” or the overall “failure of life to turn out as expected.”

The solutions to this “everything problem” are not clear. Silva told me that the opioid epidemic had made some of her interviewees even more resentful, because they saw their neighbors as too weak to pull themselves out of addiction. At times, they seemed to almost celebrate the pain of withdrawal from opioids, as a necessary way of toughening up. “They actually end up supporting programs that would give people less help or less aid, because they feel like it’s enabling to keep giving help to people who refuse to get better,” she told me.

One of Silva’s interviewees tried to convince her that stress is how people grow. But stress can also make people hurt.

Olga Khazan is a staff writer at The Atlantic.

NEXT STORY: Confucius Has a Message for Leaders Who Want to Succeed: Reflect

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.